HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DAPK promotor methylation is an early event in colorectal carcinogenesis.

Abstract
Death-associated protein kinase (DAPK) is frequently inactivated by promotor hypermethylation in various human cancers. At present, little is known about the significance of DAPK inactivation in colorectal carcinogenesis. We therefore, investigated macrodissected samples of 22 formalin-fixed and paraffin-embedded T1-carcinomas showing normal colon mucosa, intraepithelial neoplasia and carcinoma tissue on the same slice. Dissected carcinoma areas showed a higher frequency of DAPK promotor methylation (81.2%) compared to intraepithelial neoplasia (68.2%). Colon mucosa adjacent to intraepithelial neoplasia or carcinoma showed DAPK promotor methylation in only two of eight cases (25%). We suggest that DAPK promotor hypermethylation may play an important role in the early steps of tumor progression in colorectal carcinoma.
AuthorsFalk Mittag, Doerthe Kuester, Michael Vieth, Brigitte Peters, Bernd Stolte, Albert Roessner, Regine Schneider-Stock
JournalCancer letters (Cancer Lett) Vol. 240 Issue 1 Pg. 69-75 (Aug 18 2006) ISSN: 0304-3835 [Print] Ireland
PMID16246486 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Apoptosis Regulatory Proteins
  • Biomarkers, Tumor
  • Death-Associated Protein Kinases
  • Calcium-Calmodulin-Dependent Protein Kinases
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Apoptosis Regulatory Proteins (genetics, metabolism)
  • Biomarkers, Tumor (metabolism)
  • Calcium-Calmodulin-Dependent Protein Kinases (genetics, metabolism)
  • Carcinoma in Situ (enzymology, genetics, pathology)
  • Cell Transformation, Neoplastic (genetics, metabolism)
  • Colorectal Neoplasms (enzymology, genetics, pathology)
  • DNA Methylation
  • Death-Associated Protein Kinases
  • Female
  • Gene Expression Regulation, Neoplastic
  • Gene Silencing
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Promoter Regions, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: